Researchers Lu and colleagues have proven that restin can prevent EMT in breast cancer by binding to p73, activating miR-200a/b, and thereby decreasing the production of ZEB1/2, which are master transcription factors for EMT (48). This evidence concerns the gene ZEB1 and breast cancer.